tiprankstipranks
Trending News
More News >

Everest Medicines Announces Virtual AGM with Key Resolutions

Story Highlights
Everest Medicines Announces Virtual AGM with Key Resolutions

Confident Investing Starts Here:

An update from Everest Medicines Ltd. ( (HK:1952) ) is now available.

Everest Medicines Ltd. has announced that its Annual General Meeting (AGM) will be held virtually on June 27, 2025. Key agenda items include the adoption of the company’s financial statements for 2024, re-election of executive directors, re-appointment of Ernst & Young as auditors, and granting of mandates to repurchase shares and issue additional shares. These resolutions aim to strengthen the company’s governance and operational flexibility, potentially enhancing its market position and shareholder value.

The most recent analyst rating on (HK:1952) stock is a Hold with a HK$48.32 price target. To see the full list of analyst forecasts on Everest Medicines Ltd. stock, see the HK:1952 Stock Forecast page.

More about Everest Medicines Ltd.

Everest Medicines Ltd. is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs in Asia and other emerging markets. The company specializes in innovative therapies across various therapeutic areas, including oncology, autoimmune disorders, cardio-renal diseases, and infectious diseases.

Average Trading Volume: 5,331,989

Technical Sentiment Signal: Buy

Current Market Cap: HK$13.94B

Learn more about 1952 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App